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Peripheral axons from auditory spiral ganglion
neurons (SGNs) form an elaborate series of radially
and spirally oriented projections that interpret com-
plex aspects of the auditory environment. However,
the developmental processes that shape these
axon tracts are largely unknown. Radial bundles are
comprised of dense SGN fascicles that project
through otic mesenchyme to form synapses within
the cochlea. Here, we show that radial bundle fascic-
ulation and synapse formation are disrupted when
Pou3f4 (DFNX2) is deleted from otic mesenchyme.
Further, we demonstrate that Pou3f4 binds to and
directly regulates expression of Epha4, Epha4/
mice present similar SGN defects, and exogenous
EphA4 promotes SGN fasciculation in the absence
of Pou3f4. Finally, Efnb2 deletion in SGNs leads to
similar fasciculation defects, suggesting that eph-
rin-B2/EphA4 interactions are critical during this
process. These results indicate a model whereby
Pou3f4 in the otic mesenchyme establishes an Eph/
ephrin-mediated fasciculation signal that promotes
inner radial bundle formation.
INTRODUCTION
Hearing depends on hair-cell-mediated conversion of sound
stimuli into electrochemical information that is then relayed to
the brain via spiral ganglion neurons (SGNs), a cluster of bipolar
afferent neurons that parallel the medial surface of the cochlear
coil. Although considerable research has been conducted on the
patterning of the hair cells and support cells within the cochlea
(Driver and Kelley, 2009; Kelley, 2006; Puligilla and Kelley,
2009), relatively little work has focused on mechanisms that
control the patterning, migration, and outgrowth of the SGNs (re-
viewed in Appler and Goodrich, 2011). As essential regulators ofauditory information, a better understanding of how these
processes occur within SGNs will enhance our understanding
of auditory function, as well as how neural connections might
be reformed in cases of deafness.
During development, immature proliferating neuroblasts
delaminate from the otocyst (Ruben, 1967) and migrate to form
a dense ganglion along the medial side of the inner ear epithe-
lium. As development continues, developing SGNs extend
peripheral axons through the surrounding (otic) mesenchyme
cells (Carney and Silver, 1983) and subsequently penetrate the
cochlear epithelium to form glutamate-responsive ribbon-type
synapses with inner and outer hair cells (Smith, 1961). During
this process, SGN axons form a series of dense fascicles,
referred to as inner radial bundles, each of which contains fibers
with similar frequency tuning. Groundbreaking work has begun
to delineate the regulatory networks that establish the circuitry
between the cochlea and the central nervous system (CNS)
(Koundakjian et al., 2007); however, specific mechanisms regu-
lating SGN developmental patterning are unknown.
The POU-domain (Pit1-Oct1/2-unc86) proteins are a phyloge-
netically conserved family of transcription factors with diverse
DNA-binding affinities and a wide range of developmental func-
tions (Phillips and Luisi, 2000; Ryan and Rosenfeld, 1997). Muta-
tions in POU3F4/Pou3f4, located on the X chromosome, cause
deafness in humans (DFNX2) and mice (Kandpal et al., 1996;
Minowa et al., 1999). Expression studies indicate that Pou3f4
expression is restricted to otic mesenchyme cells, with limited
or no expression in the hair cells or SGNs (Minowa et al., 1999;
Phippard et al., 1998; Samadi et al., 2005). Consistent with
this, the cochlear sensory epithelium (organ of Corti), which
includes hair cells and supporting cells, appears normal in
Pou3f4/ mice. However, the cochlear duct has been
described as dysplastic with a moderate length reduction,
possibly owing to disorganization and altered morphology of
otic mesenchyme cells (Minowa et al., 1999; Phippard et al.,
1999). Considering the intimate relationship between developing
SGNs and otic mesenchyme, defects in aspects of SGN forma-
tion in the absence of Pou3f4 seemed possible.
Any effects of Pou3f4 on SGN formation would most likely be
indirect and therefore mediated by other factors. In particular,Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 49
Figure 1. Pou3f4 Expression during SGN
Development in Mouse
(A) At E9.5, there is no Pou3f4 expression in the
presumptive otic mesenchyme (arrows). nt, neural
tube; ot, otocyst; cvg, cochleovestibular ganglion;
D, dorsal; L, lateral.
(B) At E10.5, Pou3f4 expression commences in the
otic mesenchyme (arrows).
(C) At E12.5, SGN peripheral axon outgrowth
has started (arrowheads), and Pou3f4 protein is
expressed by all mesenchyme cells in the otic
capsule. sg, spiral ganglion; ce, cochlear epithe-
lium.
(D) Midmodiolar cross-section at E16.5. SGNs’
peripheral axons (arrowhead) project through otic
mesenchyme (arrows) to reach the cochlear
epithelium. om, otic mesenchyme; V, ventral.
(E) At P2, SGNs and glia (arrowhead) are clearly
separated from the surrounding mesenchyme
(arrows). st, scalia tympani; osl, osseous spiral
lamina; sl, spiral limbus.
(F) High-magnification image from the boxed
region in (E). Pou3f4-positive cells (arrows) within
the ganglion do not express neuron or glia
markers.
(G–I) Whole-mount view of the spiral ganglion and
otic mesenchyme at E17.5. Inner radial bundles
extend through otic mesenchyme to the cochlear
epithelium. Arrows in (H) and (I) point to mesen-
chyme cells analogous to those illustrated in (F).
(J–L) A 2-mm-thick confocal z stack from the boxed
region in (I) illustrates the separation of the axons
of the radial bundles and the mesenchyme cells.
Asterisks mark bands of mesenchyme.
(M–O) An orthogonal projection derived from
the region indicated by the dotted line in L. The
asterisks delineate the bands of mesenchyme.
For (A)–(C) and (G)–(I), the length of the scale bar in
(O) represents 150 mm; for (D) and (E), the length of
the scale bar in (O) represents 50 mm; for (F), the
scale bar in (O) represents 10 mm; for (J)–(L), the
length of the scale bar in (O) represents 30 mm; for
(M)–(O), the length of the scale bar in (O) represents
20 mm.
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Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationEph receptors, the largest family of vertebrate receptor tyrosine
kinases, are known to interact with ephrin ligands to generate
both forward and reverse signals and have been linked exten-
sively with axon guidance (Coate et al., 2009; Huai and Drescher,
2001; Pasquale, 2005;Wilkinson, 2001). Although several studies
have documented the presence of Ephs and ephrins in the inner
ear (Bianchi and Gale, 1998; Zhou et al., 2011), a role for fascicu-
lation and/or radial bundle formation has not been described.
RESULTS
Pou3f4 Is Expressed by Otic Mesenchyme Cells during
All Stages of SGN Development
Pou3f4 expression in the otic mesenchyme has been described
previously (Ahn et al., 2009; Phippard et al., 1998), but those
studies did not determine whether other cells nearby, such as
SGNs or associated glia, were also positive for Pou3f4. Thus,
we conducted a comprehensive temporal and spatial analysis of50 Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc.Pou3f4 protein expression during SGN development using
aPou3f4-specificantibody, alongwithmarkersofmatureauditory
neurons (Tuj1) and Schwann cells (Sox10; Puligilla et al., 2010). In
mice, SGNs develop within the cochleovestibular ganglion (cvg),
a transient structure formed by neuroblasts that delaminate
from the ventral-medial side of the otocyst at embryonic day (E)
9.5 (Figures 1A and 1B). At E9.5, Pou3f4 expression in the
presumptivemesenchyme is not detectable (Figure 1A); however,
at E10.5, small patches of Pou3f4-expressing mesenchyme cells
emerge adjacent to the cvg (Figure 1B, see arrows). By E12.5,
when the auditory and vestibular components of the inner ear
have diverged (Koundakjian et al., 2007), Pou3f4 is detectable in
all compartments of the otic mesenchyme (Figure 1C). At this
stage, neural crest-derived Schwann cells infiltrate the ganglia,
and SGNs begin to project peripheral axons toward the prosen-
sory domain located within the cochlear epithelium (Carney and
Silver, 1983). At these early stages, Pou3f4 is detectable in otic
mesenchymecells, but not inneurons, glia, or epithelia.Moreover,
Figure 2. Absence of Pou3f4 Causes Defects in Fasciculation of Inner Radial Bundles
(A–C) Representative images of the base (A) and apex (C) from a Pou3f4y/+cochlea at E17.5. Arrowheads point to appropriately formed inner radial bundles;
asterisks label bands of otic mesenchyme cells.
(D–F)Whole-mount images as in (A)–(C) but fromPou3f4y/. Arrows point to defasciculated axons. The black arrow (with white stroke) points to the intraganglionic
spiral axon bundle (Simmons et al., 2011) that also shows fasciculation defects.
(E) Glial cells display a similar ectopic pattern.
(G) At E15.5, the inner radial bundles are apparent (arrowheads), as well as regions of mesenchyme (asterisks).
(H) Pou3f4y/ cochlea at E15.5. Fasciculation defects are already evident. Scale bar represents 50 mm.
(I and J) Illustration of the scheme by which the radial bundle phenotype was quantified.
(K and L) Histograms illustrating significant increases in axon fasciculation defects (K) and the number of times per 500 mm that individual processes
cross between fascicles (L) in Pou3f4y/ cochleae. Percentages indicate the position along the length of the cochlea with respect to the distance from the base.
**p% 0.01; ***p% 0.001.
(M) The density of neurons along the length of the cochlea is unchanged between Pou3f4y/+ and Pou3f4y/ mice.
(K–M) Mean ± SEM. Scale bar represents 50 mm.
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Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationPou3f4-expressing mesenchyme cells appear to make direct
contact with the distal ends of the SGN peripheral axons (Fig-
ure 1C, arrowheads) in regions where Schwann cells have not
yet arrived. At E16.5, SGN peripheral axon outgrowth continues
along the length of the cochlea as theoticmesenchyme (om) pop-
ulationexpands to form the future osseousspiral lamina andspiral
limbus (osl and sl, respectively; Figures 1D and 1E). The adult osl
consists of bony plates that surround the SGN axons, and the sl is
a thickened periosteum. At E15.5–E16.5, radial bundles form
concurrently with the appearance of bands of mesenchyme cells
located between SGN peripheral axons (as in Figure 2G, aster-
isks). By P2, Pou3f4-positive mesenchyme cells segregate fromextending SGN axons, with clearly visible boundaries (Figure 1E).
Occasional Pou3f4-positive cells were observedwithin the somal
layer of the spiral ganglion (Figure 1E), but these cells were not
positive for either Tuj1 or Sox10, suggesting that they are mesen-
chyme cells that have interspersed the ganglion during develop-
ment (arrows in Figures 1E and 1F). In whole mount at E17.5,
the segregation of the peripheral axons and the oticmesenchyme
is dramatic: groups of 50–100 axons fasciculate to form rela-
tively evenly spaced inner radial bundles along the length of the
cochlea (Figures 1G–1I). Higher-magnification images show
how axons travel in areas that are devoid of Pou3f4 and rarely
cross between bundles (Figures 1J–1O).Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 51
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Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationRadial Bundle Fasciculation Is Lost inPou3f4y/–Embryos
Previously,Pou3f4mutantswere shown to have variable levels of
hypoplasia of the otic mesenchyme and severe hearing impair-
ment (Minowa et al., 1999; Phippard et al., 1999). Therefore, we
hypothesized that if SGN fasciculation and otic mesenchyme
organization are interdependent, then inner radial bundle forma-
tion may require Pou3f4. To test this hypothesis, we compared
radial bundle development in whole-mount preparations of
Pou3f4y/+ and Pou3f4y/ cochleae (Figures 2A–2H). At E17.5,
Pou3f4y/+ cochleae contained dense, well-organized fascicles
that projected directly from theSGNsoma to the cochlear epithe-
lium (Figures 2A–2C). This pattern is most conspicuous at the
base of the cochlea (Figures 2A and 2B) but is also evident at
the apex (Figure 2C),where thebundles are always less compact.
In contrast, SGNaxons inPou3f4y/ embryos failed to fasciculate
properly, formed loosely compacted bundles, and contained
increased numbers of laterally projecting processes (Figures
2D–2F). Although this fasciculation phenotype could arise from
a deficit of auditory glia (Breuskin et al., 2010), there appeared
to be no defect in their development (Figure 2E; Sox10 staining).
Fasciculation defectswere evident inPou3f4y/ embryos as early
as E15.5 (Figures 2G and 2H), suggesting disruptions during the
early phases of axon outgrowth.
To quantify fasciculation along the length of the cochlea, we
measured the total area occupied by SGN axons between the
soma and the sensory epithelium (see Experimental Procedures;
Figures 2I and 2J). In base, middle, and apical regions of the
cochlea, the SGN axons in Pou3f4y/ embryos consumed sig-
nificantly more space compared to their wild-type littermates
(Figure 2K), with the greatest difference in fasciculation present
at the apex (80% versus 91%, respectively; see Figure 2K,
light gray bars). In addition, the frequency with which processes
crossed between fascicles was significantly greater in Pou3f4y/
embryos compared to wild-type (Figure 2L; arrows in Figure 2D).
Pou3f4y/ cochleae have been reported to be slightly shorter
than controls, which raised the possibility that the SGN fascicu-
lation defects might result from changes in neuron numbers
along the length of the cochlea. However, a comparison of the
density of SGN cell bodies between Pou3f4y/+ and Pou3f4y/
cochleae indicated no significant differences (Figure 2M; see
also Figure S1 available online).
To determine whether a loss of surrounding otic mesenchyme
cells caused the SGN fasciculation defects in Pou3f4y/ mice,
we compared the frequency of apoptotic cells in the otic mesen-
chymebetweenPou3f4y/+ andPou3f4y/ animals using antibodies
against cleavedcaspase-3 (CC3) (FiguresS1E–S1J).Wealsoused
DAPI to look for potential necrotic lesions (Figures S1L–S1O).
Although the density of the mesenchyme cells appeared to be
slightly lower in Pou3f4y/ animals (compare the outlined areas in
Figures S1G and S1J), there was no enhanced apoptosis or
necrosis in the otic mesenchyme cells (Figures S1K–S1O).
Innervation and Ribbon Synapse Formation Are
Diminished in Pou3f4y/– Embryos
Axon fasciculation reduces pathfinding errors and provides
efficient innervation of target tissues (Tessier-Lavigne and
Goodman, 1996). Considering the fasciculation defects in the
Pou3f4y/ cochleae, we examined possible changes in innerva-52 Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc.tion. SGNs are subdivided into two classes: type I SGNs (90% of
the entire population), which form synapses on inner hair cells,
and type II SGNs (the remaining 10%), which grow past the inner
hair cell layer, cross the tunnel of Corti, and then turn toward the
base before forming synapses with outer hair cells (Huang et al.,
2007; Koundakjian et al., 2007). At the base of wild-type
cochleae at E17.5, Tuj-l immunolabeling shows the dense layer
of type I SGN endings, as well as type II processes that cross
the pillar cell layer before turning toward the base (Figure 3A).
These preparations were counterstained with Sox10 antibodies
to reveal the morphology of the cochlear epithelium with respect
to the SGNs (Figures 3B and 3C). Images acquired at the mid-
base, midapex, and apex (Figures 2D–2F) illustrate the base-
to-apex maturation of the type II processes. In comparison
with Pou3f4y/+ embryos, Pou3f4y/ embryos at E17.5 showed
diminished innervation by both types of SGNs: the type I layer
of Pou3f4y/ embryos was narrowed and less robust (see
brackets, Figures 3G–3L), and the number of type II processes
was substantially reduced (Figures 3G–3L). In addition, the
type II processes that were present appeared to be shorter and
less mature (Figures 3J and 3K) or had not extended (Figure 3L).
Sox10 immunostaining indicated no changes in the morphology
of the supporting cells in Pou3f4y/ cochleae (Figures 3H and 3I).
These data suggest that fasciculation defects result in dimin-
ished target innervation within the cochlear epithelium.
We therefore reasoned that synapse numbers between SGNs
and hair cells would also be reduced in Pou3f4y/ mice. In hair
cells, 500 nm ribbon-type synapses can be visualized and
quantified using anti-Ribeye antibodies (Meyer et al., 2009;
Figures 3M–3P). Postsynaptic glutamate receptor immunoreac-
tivity has a diffuse appearance at early postnatal stages but is
suitable for qualitative observations (Nemzou N et al., 2006;
Figures 3M–3P). Comparisons at postnatal day eight (P8) indi-
cated fewer ribbon synapses and lower levels of glutamate
receptor immunoreactivity in Pou3f4y/ mice (Figures 3M–3P).
Cross-sections of cochleae at P8, immunostained with neurofila-
ment and Ribeye antibodies, confirmed a decrease in the density
of type I SGN endings and showed a quantifiable decrease in the
number of ribbon synapses (Figures 3Q–3X). Consistent with the
gradient in innervation defects, the decrease in ribbon synapses
was also graded with a mild effect in the base of the cochlea and
a more severe effect at the apex (reduced by approximately
30%). These data suggest that disrupting fasciculation impairs
the ability of SGNs to locate their targets and form synapses.
Expression of EphA4 Is Reduced in Otic Mesenchyme
Lacking Pou3f4
Fasciculation is typically mediated by cell-surface or secreted
factors (Tessier-Lavigne and Goodman, 1996); therefore, we
hypothesized that otic mesenchyme cells from Pou3f4y/ mice
might fail to express one or multiple factors that directly promote
SGN fasciculation. Microarray results (see Experimental Proce-
dures) comparing mRNAs from Pou3f4y/+ and Pou3f4y/mesen-
chyme showed a significant loss of Epha4. EphA4 is one of 15
different Eph receptors that interact at the cell-cell interface
with nine possible cell surface-bound ephrin ligands to serve
diverse developmental functions, including axon repulsion and
attraction (Eberhart et al., 2002; Kullander and Klein, 2002),
Figure 3. Defects in Fasciculation in Pou3f4y/– Mice Impair Innervation and Synapse Formation
(A–L) Type I and type II projections in Pou3f4y/+ and Pou3f4y/ embryos at E17.5. Only the distal 10 mm of the type I fibers are shown. Scale bar in (L) represents
50 mm.
(A–C) At the base of the cochlea, type I fibers innervate the inner hair cell layer, whereas type II fibers cross the pillar cell layer (shown in A and C) and then turn
toward the base.
(D–F) Illustration of the base-to-apex gradient of maturation of type II fibers. At E17.5, type II projections are abundant in the midbase, sparse in the midapex, and
short at the apex (arrows).
(G–I) In Pou3f4y/ embryos at E17.5, the type I layer is less dense (see bracketed regions), and there are fewer type II projections (arrowheads).
(J–L) Compared with wild-type, Pou3f4y/ embryos show fewer, less-mature type II projections. At the apex (L), no type II projections are observed. Scale bar
represents 40 mm.
(M–P) Whole-mount preparation of the apex of Pou3f4y/+ and Pou3f4y/ cochleae at P8. Anti-Ribeye immunostaining indicates ribbon synapses (see arrow in M).
This antibody also recognizes CtBp2 (n in all hair cell nuclei). IHC, inner hair cell. Anti-GluR2/3 in (N) indicates postsynaptic glutamate receptors. Immunostaining
for both factors in the mutant appears reduced (arrowheads). Scale bar in (P) represents 8 mm.
(Q and R) Midmodiolar cross-sections of the inner hair cell region from Pou3f4y/+ (Q) and Pou3f4y/ (R) cochleae at E17.5. Nerve terminals are marked by an-
tineurofilament (200 kDa). Note the decreased density of nerve fibers contacting the inner hair cell in Pou3f4y/ (arrowheads). Scale bar in (R) represents 5 mm.
(S and T) A high-magnification view of the synaptic region from the inner hair cell in (Q). Punctate spots (circled in T) represent individual ribbon synapses.
(U and W) Similar view as in (S) and (T) but from the Pou3f4y/ inner hair cell in (R). Note the decreased number of ribbon puncta. Scale bar represents 4 mm.
(X) Histogram indicating a significant decrease in the number of inner hair cell synapses (mean ± SEM) in Pou3f4y/ cochleae at P8. **p% 0.01; ***p% 0.001.
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Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculationcooperative axon targeting (Gallarda et al., 2008), and axon
fasciculation (Bossing and Brand, 2002; Orioli et al., 1996).
Therefore, the developmental expression pattern of EphA4 in
the cochlea was examined (Figures 4A–4F). Through the use of
in situ hybridization, we found that Epha4 mRNA is broadlydistributed at E14.5 (data not shown) and E16.5 (Figures 4A
and 4B), localizing to mesenchyme, the spiral ganglion, and
the cochlear epithelium. However, we saw a remarkably limited
pattern of expression with antibodies specific to the extracellular
domain of EphA4 protein: virtually all immunoreactivity wasNeuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 53
Figure 4. EphA4 Is Expressed in the Otic Mesenchyme during Development and Is Decreased in Pou3f4y/– Embryos
(A and B) Epha4 in situ hybridization in the E16.5 cochlea. (A) displays antisense and (B) shows sense. Sg, spiral ganglion; om, otic mesenchyme; ce, cochlear
epithelium.
(C and D) EphA4 immunostaining at E14.5. Note the absence of EphA4 in all tissues except the otic mesenchyme. The dotted lines delineate the cochlear
epithelia.
(E–H) EphA4 immunostaining at E16.5. (G) and (H) are a high-magnification view of the bracketed regions in (E) and (F). Note the ‘‘guide rails’’ marked by the
asterisks and the absence of EphA4 staining in the SGN axons (arrowheads).
(I–K) Whole-mount preparation of a cochlea at E18.5. EphA4 expression is restricted to the mesenchyme (asterisks).
(L–N) Orthogonal confocal reconstructions from the dotted line in (K).
(O) Quantitative PCR data showing that Epha4 expression levels are reduced approximately 5-fold in otic mesenchyme from Pou3f4y/ embryos (mean ± SEM).
*p% 0.05.
(P–U). EphA4 expression in wild-type and Pou3f4y/ embryos (where it is reduced; see arrowheads) in whole mount at E17.5.
For (A) and (B), the scale bar in (U) represents 120 mm; for (C)–(F), the scale bar in (U) represents 100 mm; for (G)–(K), the scale bar in (U) represents 50 mm; for
(L)–(N), the scale bar in (U) represents 15 mm; for (P)–(U), the scale bar represents 70 mm.
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Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculationobserved in otic mesenchyme cells (Figures 4C–4F). A high-
magnification view of the SGN peripheral axons (Figures 4G
and 4H) shows that EphA4 protein is expressed only by the54 Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc.adjacent mesenchyme cells in a ‘‘guide rails’’ fashion (see
asterisk, Figures 4G and 4H) but is not detectable in the SGN
axons (arrowheads) themselves. Importantly, whole-mount
Neuron
Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculationpreparations and orthogonal reconstructions of E18.5 cochleae
show that EphA4 is distributed in the Pou3f4-positive mesen-
chyme bands between the SGN fascicles but does not overlap
with Tuj1 (Figures 4I–4N). These results indicate that EphA4
protein is distributed in a spatial and temporal manner consistent
with a role in SGN fasciculation. It is unclear why there is
a discrepancy between EphA4 mRNA and protein distribution,
but a posttranscriptional regulatory program that limits EphA4
protein to the mesenchyme may be present.
To confirm that EphA4 expression in the mesenchyme
depends on Pou3f4, we used quantitative PCR to show an
approximate 5-fold reduction in Epha4 expression in Pou3f4y/
cochleae (Figure 4O). Moreover, analyses of whole-mount prep-
arations from Pou3f4y/ cochleae show that EphA4 protein is
substantially reduced in the otic mesenchyme at E17.5 (Figures
4P–4U).
EphA4 Promotes SGN Fasciculation and Hair Cell
Innervation
If Pou3f4 transcriptional activity regulates Epha4 expression in
the otic mesenchyme to promote SGN fasciculation, we
reasoned that Epha4-deficient mice should also have fascicula-
tion defects. We therefore examined the SGNs from Epha4/
embryos at late embryonic ages (Helmbacher et al., 2000; North
et al., 2009). Compared to their wild-type littermates (Figures 5A,
5C, 5E, and 5G), Epha4/mice presented fasciculation defects
that were remarkably similar to those observed in the Pou3f4y/
animals (Figures 5B, 5D, 5F, and 5H; compare to Figure 2).
Whereas wild-type cochleae showed tight SGN bundles and
well-defined mesenchyme bands (Figures 5A and 5C), the
SGNs in Epha4/ cochleae displayed dispersed, poorly fascic-
ulated bundles that aberrantly traversed the mesenchymal
space (Figures 5B and 5D) and occupied significantly more
area at the basal, midmodiolar, and apical regions of the cochlea
(Figure 5I). Orthogonal reconstructions of these samples illus-
trate disruptions in the normal interdigitation of the mesenchyme
cells and the SGN bundles in the Epha4/ mutants (Figures 5E
and 5F). The number of mesenchyme cells in Epha4/ cochleae
appeared unchanged compared to wild-type, suggesting that
the fasciculation defects in the SGNs are not due to a loss of
surrounding mesenchyme (Figures 5G and 5H). Similar to
SGNs from Pou3f4y/ mice, SGNs from Epha4/ mice showed
an approximately 4-fold increase in the number of axons that
crossed between bundles (Figure 5J). Finally, we examined
Epha4/ cochleae at P7 to determine whether these animals
(like Pou3f4y/ mice) had defects in hair cell innervation and
ribbon synapse formation (Figure S2). As a result of early post-
natal lethality of this line, we were only able to examine four
mutant ears, and thus our conclusions are based on a limited
sampling. Compared to controls (Figures S3A, S3C, and S3D),
Epha4/ mice showed a nearly 2-fold reduction in the number
of ribbon synapses (Figures S2B, S2E, and S2F), further support-
ing that SGN fasciculation is important for target innervation.
Overall, the fasciculation and synapse defects in Epha4 and
Pou3f4 mutants are very similar, consistent with their participa-
tion in a common developmental process.
To investigate whether EphA4 plays a non-cell-autonomous
role during SGN fasciculation, we asked whether exogenousEphA4 extracellular domains (serving as a substitute for mesen-
chyme) could promote SGN fasciculation in vitro. E12.5 spiral
ganglia were cultured for 24 hr (without otic mesenchyme) on
a layer of Matrigel infused with either control Fc or EphA4-Fc
(Figures 5K–5M) to determine the effects on fasciculation. We
also examined the effects of preclustering EphA4-Fc to deter-
mine whether ‘‘activating’’ (preclustered form) or ‘‘blocking’’ (un-
clustered form) ephrin ligands on the SGNs had different effects
on fasciculation (Davis et al., 1994). In the presence of control Fc
(preclustered), SGN explants projected mostly single neurites
and some rudimentary fascicles (Figure 5K, see arrowheads),
suggesting that SGNs may have some intrinsic axoaxonal
binding capacity. However, explants cultured with preclustered
EphA4-Fc showed dramatically enhanced fasciculation, with
thick bundles projecting away from the soma (Figure 5L) and
very few single neurites. Interestingly, EphA4-Fc treatments did
not reduce the length of axons (growth cone collapse) compared
to controls (data not shown). When we stained these cultures
with anti-integrin-a6 antibodies to mark the auditory glia, we
found their growth pattern to be almost identical to that of the
SGNs, raising the possibility that the glia may also respond to
EphA4. However, when the SGNs were eliminated in the pres-
ence of high pH culture medium (Mukai et al., 2011) but grown
in preclustered EphA4-Fc, the glia persisted but did not bundle
(Figure 5M), suggesting that SGN fasciculation is not normally
a secondary response to aggregating glia. Preclustered
EphA4-Fc at 10 nM led to a 4-fold increase in average bundle
diameter compared to controls (Figure 5N) and doubled
the percentage of fascicles greater than 3.5 mm in diameter
(Figure 5O). Importantly, cultures grown in the presence of un-
clustered EphA4-Fc showed levels of bundling that were not
significantly different from controls (see Figures 5N and 5O), sug-
gesting that blocking ephrins from recognizing Eph receptors on
neighboring axons or glia has little effect on SGN fasciculation.
These results demonstrate that EphA4, expressed by mesen-
chyme cells, may normally activate ephrin ligands expressed
by SGNs to promote fasciculation.
Pou3f4 Knockdown In Vitro Causes SGN Fasciculation
Defects that Are Rescued by EphA4
To determine whether Pou3f4 and EphA4 are functionally linked,
we established an in vitro system to investigate SGN fascicula-
tion using explanted SGNs and otic mesenchyme. At E12.5,
the auditory component of the cochleo-vestibular ganglion can
be easily isolated and cocultured with pieces of otic mesen-
chyme; over time these cell populations intercalate, while devel-
oping SGNs extend processes (Figure 6A; Figure S3). In these
assays, the SGNs appear to briefly migrate away from the
explant and then extend axons (often in clusters with other
neurons; see Figure S3) at the same time that mesenchyme cells
invade. In addition, coculturing the SGNs and mesenchyme in
a thick Matrigel layer allows the two cell populations to interact
in a semi-three-dimensional gel, mimicking SGN fasciculation
in vivo (Figures S3B and S3C). To examine the effects of
decreased expression of Pou3f4, we used Morpholino antisense
oligonucleotides (MOs) to knock down Pou3f4. Figure 6A shows
uptake of a control MO- fluorescein isothiocyanate (FITC)
conjugate by endocytic vesicles in mesenchyme and neurons.Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 55
Figure 5. Epha4/EphA4 Promotes SGN Fasciculation and Hair Cell Innervation
(A and B) Wild-type (A) and Epha4/ (B) cochleae at E18.5. Arrowheads in (A) point to well-defined SGN fascicles, and asterisks mark normally formed bands of
mesenchyme. In contrast, less SGN fasciculation and axons inappropriately traverse the mesenchyme (arrows) in the Epha4/ cochlea (B).
(C and D) High-magnification views of wild-type (C) and Epha4/ (D) cochleae at E17.5 illustrating how the SGNs fail to bundle.
(E and F) Orthogonal reconstructions from the regions marked by dotted lines in (C) and (D) showing that the SGN bundles and mesenchyme are no longer
segregated.
(G and H) Monochrome images indicate no change in Pou3f4 expression in Epha4/ cochleae.
(I and J) Histograms illustrate the axon fasciculation defects (I) and the number of times per 500 mm that individual processes crossed between fascicles (J).
Percentages indicate the position along the length of the cochlea with respect to the distance from the base. **p% 0.01; ***p% 0.001.
(K and L) E12.5 SGNexplants cultured for 24 hr in the presence ofMatrigel + Fc control orMatrigel + EphA4-Fc (both preclustered forms). Themiddle panels show
the auditory glia (Int a6 positive).
(M) Same as (L), but the neurons were eliminated using high pH culture medium.
(N and O) Histograms showing increased fascicle diameter (N) and percentage of large (R3.5 mm) fascicles in response to EphA4-Fc. **p% 0.01; ***p% 0.001.
For (A) and (B), the length of the scale bar in (H) represents 50 mm; for (C), (D), (G), and (H), the length of the scale bar in (H) represents 20 mm; for (E) and (F), the
length of the scale bar in (H) represents 15 mm. The scale bar in (M) represents 100 mm. DIV indicates days in vitro. Mean ± SEM for (I), (J), (N), and (O).
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Figure 6. Exogenous EphA4 Protein
Rescues Pou3f4-Dependent Fasciculation
Defects In Vitro
(A) Coculture of SGNs (purple) and mesenchyme
cells. Punctate FITC-labeling indicates uptake of
FITC-conjugated control MO by endocytic vesi-
cles.
(B) Western blot demonstrating knockdown of
endogenous Pou3f4 by a Pou3f4 MO. Lane 1,
20 mM control MO; lane 2, 1 mMPou3F4 MO; lanes
3–5, three different samples treated with 20 mM
Pou3f4 MO. Anti-b-actin, loading control.
(C) Quantitative PCR demonstrates a 5-fold
reduction of Epha4 transcripts in mesenchyme
cells treated with the Pou3f4 MO.
(D–J) SGN and otic mesenchyme cocultures
treated with indicated MO. Green, anti-Tuj1
(neurons); red, anti-Pou3f4; blue, phalloidin (actin).
(D–F) In the presence of 20 mM control MO, SGN
cell bodies cluster (arrows in D and E) and have
axons that form thick, straight fascicles that
extend away from the cell bodies (arrowheads
in F).
(G–I) Treatment with 20 mM Pou3f4 MO decreases
clustering of cell bodies (arrows in G and H) and
decreases axon fasciculation (arrowheads in I). In
addition, individual fibers follow more convoluted
paths. Knockdown of Pou3f4 is illustrated in (H).
(J) Treatment with 20 mM Pou3f4 MO + 10 nM
EphA4-Fc increases incidences of thick, straight
fascicles (arrows), although single nonfasciculated
neurites are still present (arrowheads). For panel
(A), the scale bar in (J) represents 20 mm; for (D)–(J),
the scale bar in (J) represents 40 mm.
(K and L) Histograms illustrating changes in
average fascicle diameter (mm) and average
percentage of large (R3.5 mm) fascicles among
the different treatment groups. ***p % 0.001.
Mean ± SEM for (C), (K), and (L).
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Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationA Pou3f4-specific antisense MO at 20 mM showed a nearly
complete knockdown of Pou3f4 (Figure 6B). Treatment with
the Pou3f4 MO also induced a significant knockdown of Epha4
(Figure 6C), confirming a direct effect for Pou3f4 on Epha4
expression.
The soma of SGNs maintained in coculture with control MO
were typically clustered with one another (Figures 6D and 6E),
and their neurites often formed extensive and straight fascicles
that extended through the mesenchyme cells (Figure 6F; Fig-
ure S3) (Simmons et al., 2011). In contrast, when cultures were
treated with the Pou3f4 MO, SGNs failed to form clusters
(Figures 6G and 6H). Distal processes still extended among the
otic mesenchyme cells, but these processes failed to fasciculate
and often followed more torturous paths (Figure 6I), similar to
Pou3f4y/ cochleae. To quantify these effects, we determined
average SGN fascicle diameter for both conditions. In controls,
average fascicle diameter was approximately 3.1 mm (Figure 6K;
individual SGN neurites in culture are small, typically 1 mm in
diameter), and 28%of fascicles were classified as large fascicles(larger than or equal to 3.5 mm; Figure 6L). Fascicles in Pou3f4
MO-treated cultures had a significantly smaller average diameter
of 2 mm, and only 8% of the fascicles were classified as large
(Figure 6L). To determine whether fasciculation loss was a result
of downregulating Epha4, we added EphA4-Fc protein to SGN
and mesenchyme cultures that had been treated with the
Pou3f4 MO. The addition of preclustered EphA4-Fc restored
SGN fasciculation (Figure 6J) and induced a statistically signifi-
cant increase in fascicle diameter size, as well as a 12%
enhancement of large fascicles (Figures 6K and 6L).
Ephrin-B2 Acts as a Cofactor for EphA4 during SGN
Fasciculation
We next reasoned that if EphA4 expression by otic mesenchyme
cells promotes SGN fasciculation, then at least one ephrin
cofactor must be expressed by the SGNs. Thus, an extensive
in situ hybridization survey was performed to determine which
of the seven known EphA4 ligands (Wilkinson, 2001) are ex-
pressed by SGNs during mid-to-late gestation (Figure S4;Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 57
Figure 7. Ephrin-B2 Acts as a Cofactor for EphA4 during SGN Fasciculation
(A–C) Efnb2 in situ hybridization at E13.5 and E15.5. sg, spiral ganglion; ce, cochlear epithelium; om, otic mesenchyme.
(D) Ephrin-B2 antibody staining of the cochlea at E16.5.
(E–H) High-magnification view from the boxed region in (D) shows SGNs (E), ephrin-B2 expression primarily in the neurons (F, see arrows), glial cells (G, see
arrowheads), and merge (H).
(I and J) Representative control Fc and ephrin-B2-Fc-treated samples from SGN and otic mesenchyme cultures. See main text for details.
(K and L) Histograms showing decreased average fascicle diameter (K) and percentage of large fascicles (L) in the presence of blocking ephrin-B2-Fc.
(M) Tamoxifen induction of Ngn-CreERT2 induces expression of YFP reporter activity in 95%–100% of SGNs (see Experimental Procedures).
(N) Micrograph showing morphology of the radial bundles in a control Efnb2 wt; Cre+ cochlea.
(O) Micrograph showing less fasciculation and fewer processes crossing between bundles (arrows) in Efnb2 cko; Cre+ cochlea.
(P and Q) Pou3f4 staining shows that mesenchyme is normal in both WT and Efnb2 cko cochleae.
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Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationFigure 7). For Efna1, Efna5, and Efnb3, mRNA was not detect-
able at appreciable levels in the cochlea (data not shown).
Transcripts for both Efna2 and Efna4 were distributed broadly
in the cochlea, including the spiral ganglion, and Efna3 appeared
in the SGNs but at a level just slightly above the control probe
(Figure S4). In contrast, Efnb2 was detected at high levels in
SGNs at E13.5 (Figure 7A) and at E15.5, when SGN fasciculation
commences (Figures 7B and 7C). Ephrin-B2 protein was simi-
larly detected in the SGNs and their axons by immunostaining
(Figure 7D) and overlapped primarily with neuronal markers
(Tuj1; Figures 7E, 7F, and 7H, see arrows), but not with markers
of auditory glia (integrin-a6; Figures 7G and 7H, see arrow-
heads). The complementary expression of ephrin-B2 on SGN
axons and EphA4 on adjacent mesenchyme (compare Figure 7D
to Figure 4F) suggested that ephrin-B2 is spatially and tempo-
rally positioned to interact with EphA4 during SGN fasciculation.
We next predicted that if EphA4 signals through ephrin-B2 in
this system, then blocking ephrin-B2 function using unclustered
ephrin-B2-Fc would prevent SGN fasciculation in SGN and
mesenchyme cocultures, similar to the effects of the Pou3f4
MO.Consistent with this hypothesis, ephrin-B2-Fc led to a nearly
25% decrease in fascicle diameter and a >4-fold decrease in the
number of large fascicles, as compared to control (Figures 7I–
7L). We next asked whether the loss of Efnb2 in the SGNs in vivo
would lead to fasciculation defects similar to those observed in
the Pou3f4 and Epha4 mutants. Because Efnb2 was detectable
in regions of the cochlea besides the SGNs, particularly at earlier
stages (Figures 7A, 7B, and 7D), we conditionally removed Efnb2
in the SGNs by crossing Efnb2 loxPmice (Gerety and Anderson,
2002) to mice carrying Ngn-CreERT2 (Koundakjian et al., 2007),
a transgene that shows robust reporter activity in the SGNs after
tamoxifen delivery (Figure 7M). Resulting Efnb2 conditional
knockout (cko) mice showed substantially reduced levels of eph-
rin-B2 protein, particularly in the SGN peripheral axons (Fig-
ure S4), but not in other regions of the cochlea.
Compared to Cre-positive wild-type littermate controls
(Figures 7N and 7P), the SGNs from Efnb2 cko cochleae showed
both fasciculation defects and axons that aberrantly crossed
between fascicles but did not show a loss of mesenchyme
(Figures 7O and 7Q). Although statistically significant in some
cases, these defects were less severe compared to what we
observed in the Pou3f4 or Epha4 mutants, probably owing to
functional redundancy by other ephrins present or possibly a
lack of complete ephrin-B2 elimination. Efnb2 cko cochleae
showed a 6% increase in area consumed by axons and maxi-
mally a 4-fold increase in the number of axons that crossed
between bundles (Figures 7R and 7S). Because tamoxifen was
given at a single dose at E9.5–E10.5, most defects were
observed at the base and midmodiolar regions of the cochlea,
in accordance with previous studies with Ngn-CreERT2 (Koun-
dakjian et al., 2007). Importantly, the Efnb2 cko phenotype was
similar to the fasciculation phenotypes observed in both the(R and S) Histograms illustrating axon fasciculation defects (R) and the number
Percentages indicate the position along the length of the cochlea with respect to
For (A)–(C), the length of the scale bar in (H) represents 200 mm; for (D), the length
represents 20 mm. The scale bar in (J) represents 40 mm. The scale bar in (M) rep
(R), and (S).Pou3f4 and Epha4 mutants lines, suggesting that ephrin-B2
may function as a ligand for EphA4 in this process.
Pou3f4 Associates with Epha4 Regulatory Elements
We next asked whether, in the developing otic mesenchyme,
regulatory elements of Epha4 are a direct target of Pou3f4.
Pou proteins are known to have a bipartite DNA binding system
that includes a POU-specific domain, as well as a homeobox
domain (Phillips and Luisi, 2000). Whereas the recognition
sequences of several Pou proteins have been characterized,
relatively little is known about mouse Pou3f4. However, one
report has demonstrated that Pou3f4 preferentially recognizes
the tandem homeobox sequence ATTATTA in the regulation of
the dopamine receptor 1A gene D1A (Okazawa et al., 1996).
Therefore, we scanned the entire Epha4 genomic sequence
and found four of these sites within introns in the first 70 kilo-
bases (kb) and one approximately 8.5 kb upstream of exon 1
(Figure 8A). We then performed chromatin immunoprecipitation
(ChIP) using oticmesenchyme and a Pou3f4-specific IgY and as-
sayed the resulting DNAs for these Epha4 regulatory regions
using quantitative PCR (Figure 8B). In these experiments b-actin,
Neurogenin-1, and an Epha4 site that did not contain ATTATTA
were used as negative controls; there was no significant associ-
ation at these sites with the control or Pou3f4-specific IgY.
However, all five of the putative Epha4 regulatory regions
showed preferential association (with statistical significance)
with the Pou3f4-specific IgY, with little to no association with
the control IgY (Figure 8B). These data suggest that Pou3f4
may directly regulate Epha4 in otic mesenchyme cells in order
to initiate EphA4-mediated SGN fasciculation.
DISCUSSION
The results presented in this study reveal a new and intriguing
role for otic mesenchyme in the development of cochlear inner-
vation. Moreover, the identification of additional auditory defects
arising from the absence of Pou3f4 provides insights into the
underlying basis for the deafness that occurs in both human
and murine mutants. Previous reports have demonstrated a
significant decrease in endocochlear potential that is almost
certainly a major component of the auditory dysfunction, but
the demonstration of a 30% decrease in the number of ribbon
synapses may indicate a significant loss in acuity. Although
this hypothesis cannot be tested without a mouse model in
which endocochlear potential is preserved, it would need to be
considered in terms of developing any potential therapeutic
interventions.
The results presented here identify a molecular signaling
pathway in which Pou3f4 expression in otic mesenchyme cells
directly activates Epha4, leading to the expression of EphA4 on
the surface of these cells (Figure 8C). The presence of EphA4
provides a cue that acts, along with the spatial distribution ofof times per 500 mm that individual processes crossed between fascicles (S).
the distance from the base. *p% 0.05; **p% 0.01.
of the scale bar in (H) represents 100 mm; for (E)–(H), the length of the scale bar
resents 80 mm. The scale bar in (Q) represents 40 mm. Mean ± SEM for (K), (L),
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Figure 8. Pou3f4 Protein Associates with Epha4 Regulatory
Elements
(A) A cartoon schematic of Epha4 showing the first four of 16 exons. Exons I–IV
are represented by numbered gray boxes. The numbered triangles indicate the
regions containing the putative Pou3f4 binding site ATTATTA. Primer sets were
designed to amplify these five regions after ChIP. NC site, the negative control
site.
(B) Histogram showing the number of picograms (pg) of immunoprecipitated
chomatin for each primer set. ns, not significant. *p% 0.05; **p% 0.01; ***p%
0.001. Mean ± SEM.
(C) Cartoon schematic of a proposed model. Pou3f4 in otic mesenchyme
induces expression of Epha4/EphA4, which binds to ephrin-B2 on developing
SGN axons, leading to fasciculation. As a result, SGN axons fasciculate to give
rise to the inner radial bundles.
Neuron
Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculationotic mesenchyme, to promote fasciculation of SGNs via bind-
ing to ephrin-B2 on their surfaces. Furthermore, these data
predict that EphA4 activates ephrin-B2 to generate a reverse60 Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc.signaling response to segregate the SGNs and mesenchyme
in a manner classically documented in zebrafish animal cap
assays (Mellitzer et al., 1999). However, the mechanism(s) by
which ephrin-B2 promotes fasciculation among the SGN
axons remains unclear. Ephrin-B2 reverse signaling may induce
filopodial collapse (Cowan and Henkemeyer, 2001) by the
SGNgrowth cones,which, by default,may lead them topreferen-
tially associate with neighboring axons. Or ephrin-B2 reverse
signaling may promote SGN interaxonal adhesion by signaling
to other cell-surface factors known to regulate fasciculation,
such as IgCAMs (Lin et al., 1994) and/or integrins (Baum and
Garriga, 1997).
These results reveal the molecular basis for the organizing
effects of otic mesenchyme and show a paracrine mode of
action for Pou3f4 in axon guidance. Interestingly, Pou4F2
(Brn3b) is known to regulate axon pathfinding and fasciculation
in retinal ganglion cells through an autocrine signaling pathway
(Pan et al., 2008), and inDrosophila, deletion of thePou3f4 ortho-
log ventral veins lacking (vvl) leads to defects in fasciculation and
steering of axons in the fly brain, although much of these defects
may be secondary to effects on neuronal specification (Meier
et al., 2006). In addition, although this demonstrates a role for
Eph-ephrin signaling in the initial development of the peripheral
auditory system, elegant work by Huffman and Cramer (2007)
has already demonstrated a role for EphA4 in hearing and central
auditory plasticity (Hsieh et al., 2007; Huffman and Cramer,
2007). These authors showed that, after surgically removing
the cochlea (and peripheral input to the brain), the expression
of Epha4 was critical for target selection during remodeling
(Hsieh et al., 2007; Miko et al., 2008). The functions of ephrin-
Eph receptor interactions probably go well beyond those pre-
sented here and in previous publications. As shown in Figure S4
and in previous reports, several other ephrins and Ephs are ex-
pressed in the cochlea (Bianchi and Gale, 1998; Zhou et al.,
2011) and may serve a variety of additional functions. This may
also indicate why EphA4-Fc was only able to partially rescue
the fasciculation defects in the absence of Pou3f4 (Figure 6). In
particular, axon-axon interactions by Ephs and ephrins may
also play a role in SGN radial bundle formation, similar to the
coordinated actions of motor and sensory axons, as has been
shown recently (Gallarda et al., 2008; Wang et al., 2011). Indeed,
when cultured in the absence of mesenchyme, SGNs have some
intrinsic capacity to fasciculate. Inhibiting ephrins expressed on
SGNs with unclustered EphA4-Fc did not diminish fasciculation
compared to controls (Figure 5), but a more complete character-
ization of other Eph-ephrin interactions would be required to
eliminate this possibility.
The innervation patterns of the mammalian auditory system
are remarkably complex, containing multiple fiber and bundle
types (reviewed in Appler and Goodrich, 2011). Despite a wealth
of descriptive and functional studies beginning as early as the
late 1800s, the specific functions of different fiber tracts and
neuronal cell types are only now being elucidated. Mutations in
Pou3f4, Epha4, or Efnb2 lead to defects in the formation of radial
fiber bundles, but the functions of these bundles are unknown.
Considering their regular alignment along the tonotopic axis of
the cochlea, it has been suggested that each bundlemay contain
fibers tuned to a specific frequency and that radial bundle
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frequency matching between SGNs and auditory hair cells (Ru-
bel and Fritzsch, 2002). If this is the case, then defects in radial
bundle formation, such as those reported in this study, could
lead to significant tonotopic defects in the cochlea and possibly
higher CNS auditory nuclei. This conclusion is supported by the
significant functional and morphological defects in the auditory
systems of Epha4 and Efnb2 mutant mice (Miko et al., 2008),
with auditory brainstem response waveform signatures suggest-
ing defects both peripherally and centrally. Unfortunately, the
direct roles of EphA4 and ephrin-B2 in the formation of tonotopic
organization in the auditory brainstem make it impossible to
discern the specific effects of defects in radial bundle formation
without generating inner-ear-specific mutants.
The increased number of crossing fibers and the decrease in
ribbon synapses observed in Pou3f4/Epha4/Efnb2mutants indi-
cate that fasciculation signals arising from surrounding otic
mesenchyme clearly act to prevent routing errors within the
mesenchymal space by driving SGN fibers onto existing radial
bundles. Previous studies indicated that otic mesenchyme cells
express EphA4 protein (Pickles et al., 2002; van Heumen et al.,
2000) and that EphA4 prevented outgrowth of mature SGNs
in vitro (Brors et al., 2003). However, the results presented here
demonstrate that for immature SGNs, rather than inhibiting
axon outgrowth, EphA4/ephrin-B2 interactions act to form a
barrier that promotes SGN fasciculation without affecting out-
growth. Overall, the factors that guide SGN axons during their
pathfinding remain unknown. Neurotrophin signaling through
TrkB and TrkC, although critical for growth and maintenance of
SGNs, is not required for the directed outgrowth of SGNs (Fekete
and Campero, 2007; Fritzsch et al., 2005). Additional studies will
clearly be required to identify the neurotropic factors for SGNs.EXPERIMENTAL PROCEDURES
Animal Care and Tissue Preparation
All animals used in this study were maintained in accordance with the National
Institutes of Health (NIH) Care and Use Committee. Timed pregnant CD1 mice
(Charles River Laboratories) were used for protein expression studies and
neuron and mesenchyme explant cultures. Pou3f4 mutant mice, in which the
coding region was replaced with Cre recombinase, were maintained on
a mixed background. This line phenocopies a previously published Pou3f4
knockout mouse (Phippard et al., 1999). Because Pou3f4 is on the X chromo-
some, only males were used in this study in order to avoid variability arising
from X inactivation. In order to generate hemizygous males, we crossed
Pou3f4+/ females to wild-type CD1 males. To generate conditional Efnb2
knockout animals (Efnb2 cko), we bred C57/BL6 Efnb2 flox/flox mice (Gerety
and Anderson, 2002) with mice carrying the Neurogenin (Ngn)-CreERT2 trans-
gene (Koundakjian et al., 2007) on a mixed CD1 background. Ngn1CreERT2;
Efnb2flox/+mice were crossed, and pregnant dams were gavaged with a single
dose of tamoxifen (Sigma; solubilized in flax and sunflower seed oil; 0.5 mg/
40 g body weight) at 9.5–10.5 days gestation. Through the use of this strategy,
we found Cre reporter activity in 95%–100% of SGNs at the cochlear base
(R26R-YFP; Jackson Laboratory; Figure 7).
Immunostaining and In Situ Hybridization
For whole-mount immunostaining of the SGNs, we isolated cochleae from
the vestibular components, bony capsule, and associated stria. Following
permeabilization with 0.5% Triton X-100 and blocking with 10% serum, the
cochleae were incubated overnight at 4C in primary antibodies and then
rinsed extensively. Fluorescent secondary antibodies (Invitrogen, 1:1,000)were applied for 1 hr at room temperature. For culture explants and cryopro-
tected tissue sections, we performed antibody staining as described previ-
ously (Driver et al., 2008). Confocal z stack images were obtained using an
LSM-510 (Zeiss), projected using NIH-ImageJ, and then further processed
using Adobe Photoshop. In situ hybridization was performed as described
(Raft et al., 2007). For all templates, sense controls were generated in parallel.
Tissue processing, sectioning, hybridization, and detection were performed as
previously described (Raft et al., 2007).
Neuron and Mesenchyme Culture Experiments
CD1 embryos were prepared for culture experiments as described previously
(Montcouquiol et al., 2003). Culture medium included Dulbecco’s modified
Eagle’s medium, 10% fetal bovine serum, 0.2%N2, and 0.001%ciprofloxacin.
In pilot experiments, we determined that the spiral ganglion persisted in culture
up to 5 days without additional neurotrophins only if the glia were not removed.
For the 24 hr Matrigel outgrowth assays, MatTek dishes were coated (24 hr
at 37C) with 10% Matrigel mixed with either human IgG-Fc (Jackson
Immunoresearch) or EphA4-Fc (R&D Systems). To precluster the Fc fusion
proteins for some experiments, we combined each Fc protein with mouse-
anti-human Fc (Jackson Immunoresearch) for 1 hr at a 1:10 molar ratio. For
each experiment, the spiral ganglion was removed at E12.5 and placed onto
a precoated dish with normal culture medium and permitted to grow for 24 hr.
For neuron and mesenchyme coculture experiments, a spiral ganglion and
an equivalent-sized portion of otic mesenchyme were removed from the
cochlea at E12.5 and transferred to Matrigel-coated MatTek dishes (5% for
1 hr at 37C), containing solutions of either standard control MO or a
Pou3f4-specific MO (GATCCTCTACTAGTTATAATGTGGC). Neuron and
mesenchyme explants were plated approximately 1 mm from each other
before receiving Endo-Porter (0.6% final; Gene Tools) to facilitate delivery of
the MOs. After 2 days at 37C, the MO and Endo-Porter-containing medium
was replaced with normal culture medium and grown an additional 3 days.
For some experiments, soluble preclustered human IgG-Fc or EphA4-Fc
was added to cultures following 2 days Morpholino exposure. Both IgG-Fc
and EphA4-Fc were used at 10 nM based on a previous report (Brors et al.,
2003). For culture experiments comparing Fc versus ephrin-B2-Fc (R&D
Systems), we did not perform preclustering.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Jhingory et al., 2010) but with
minor modification. E15.5 cochleae were isolated in chilled PBS and then fixed
for 20 min using 4% paraformaldehyde. The Agarose ChIP Kit (Pierce) was
used for subsequent DNA digestion and precipitation. Approximately 8 mg of
chicken anti-Pou3f4 or chicken IgY (negative control) and PrecipHen beads
(Aves Labs) was used for IP. With resulting DNAs, we performed qPCR using
SYBR Green. For each primer set, a standard curve was generated using
mouse genomic DNA; control and experimental Ct values were compared to
this standard curve for quantification. The data here represent at least two
independent ChIPs and three qPCR analyses for each primer set.
Please see Supplemental Experimental Procedures for lists of the anti-
bodies, in situ hybridization probes, qPCR primers, quantification methods
used in the study, and a description of the microarray that identified Epha4.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
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ACKNOWLEDGMENTS
We thank the members of the Kelley laboratory for their valuable discussions
and technical assistance during this work. We thank Dr. Lisa Cunningham
(NIH/National Institute on Deafness and other Communication Disorders
[NIDCD]), Dr. Doris Wu (NIH/NIDCD), and Dr. Maria J. Donoghue (Georgetown
University) for the critical reading of this manuscript. Epha4 null tissue was
a kind gift from Dr. Maria J. Donoghue. Mr. Jonathan Stuckey was very helpfulNeuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 61
Neuron
Pou3f4/EphA4 in Spiral Ganglion Axon Fasciculationwith the illustration in Figure 8. The National Deafness and Other Communica-
tion Disorders Intramural Research Program funded this work.
Accepted: October 5, 2011
Published: January 11, 2012REFERENCES
Ahn, K.J., Passero, F., Jr., and Crenshaw, E.B., 3rd. (2009). Otic mesenchyme
expression of Cre recombinase directed by the inner ear enhancer of the Brn4/
Pou3f4 gene. Genesis 47, 137–141.
Appler, J.M., and Goodrich, L.V. (2011). Connecting the ear to the brain:
Molecular mechanisms of auditory circuit assembly. Prog. Neurobiol. 93,
488–508.
Baum, P.D., and Garriga, G. (1997). Neuronal migrations and axon fascicula-
tion are disrupted in ina-1 integrin mutants. Neuron 19, 51–62.
Bianchi, L.M., and Gale, N.W. (1998). Distribution of Eph-related molecules in
the developing and mature cochlea. Hear. Res. 117, 161–172.
Bossing, T., and Brand, A.H. (2002). Dephrin, a transmembrane ephrin with
a unique structure, prevents interneuronal axons from exiting the Drosophila
embryonic CNS. Development 129, 4205–4218.
Breuskin, I., Bodson, M., Thelen, N., Thiry, M., Borgs, L., Nguyen, L., Stolt,
C., Wegner, M., Lefebvre, P.P., and Malgrange, B. (2010). Glial but not
neuronal development in the cochleo-vestibular ganglion requires Sox10.
J. Neurochem. 114, 1827–1839.
Brors, D., Bodmer, D., Pak, K., Aletsee, C., Scha¨fers, M., Dazert, S., and Ryan,
A.F. (2003). EphA4 provides repulsive signals to developing cochlear ganglion
neurites mediated through ephrin-B2 and -B3. J. Comp. Neurol. 462, 90–100.
Carney, P.R., and Silver, J. (1983). Studies on cell migration and axon guidance
in the developing distal auditory system of the mouse. J. Comp. Neurol. 215,
359–369.
Coate, T.M., Swanson, T.L., and Copenhaver, P.F. (2009). Reverse signaling
by glycosylphosphatidylinositol-linked Manduca ephrin requires a SRC family
kinase to restrict neuronal migration in vivo. J. Neurosci. 29, 3404–3418.
Cowan, C.A., and Henkemeyer, M. (2001). The SH2/SH3 adaptor Grb4 trans-
duces B-ephrin reverse signals. Nature 413, 174–179.
Davis, S., Gale, N.W., Aldrich, T.H., Maisonpierre, P.C., Lhotak, V., Pawson, T.,
Goldfarb, M., and Yancopoulos, G.D. (1994). Ligands for EPH-related receptor
tyrosine kinases that require membrane attachment or clustering for activity.
Science 266, 816–819.
Driver, E.C., and Kelley, M.W. (2009). Specification of cell fate in the mamma-
lian cochlea. Birth Defects Res. C Embryo Today 87, 212–221.
Driver, E.C., Pryor, S.P., Hill, P., Turner, J., Ru¨ther, U., Biesecker, L.G., Griffith,
A.J., and Kelley, M.W. (2008). Hedgehog signaling regulates sensory cell
formation and auditory function in mice and humans. J. Neurosci. 28, 7350–
7358.
Eberhart, J., Swartz, M.E., Koblar, S.A., Pasquale, E.B., and Krull, C.E. (2002).
EphA4 constitutes a population-specific guidance cue for motor neurons. Dev.
Biol. 247, 89–101.
Fekete, D.M., and Campero, A.M. (2007). Axon guidance in the inner ear. Int. J.
Dev. Biol. 51, 549–556.
Fritzsch, B., Pauley, S., Matei, V., Katz, D.M., Xiang, M., and Tessarollo, L.
(2005). Mutant mice reveal themolecular and cellular basis for specific sensory
connections to inner ear epithelia and primary nuclei of the brain. Hear. Res.
206, 52–63.
Gallarda, B.W., Bonanomi, D., Mu¨ller, D., Brown, A., Alaynick, W.A., Andrews,
S.E., Lemke, G., Pfaff, S.L., and Marquardt, T. (2008). Segregation of axial
motor and sensory pathways via heterotypic trans-axonal signaling. Science
320, 233–236.
Gerety, S.S., and Anderson, D.J. (2002). Cardiovascular ephrinB2 function is
essential for embryonic angiogenesis. Development 129, 1397–1410.62 Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc.Helmbacher, F., Schneider-Maunoury, S., Topilko, P., Tiret, L., and Charnay,
P. (2000). Targeting of the EphA4 tyrosine kinase receptor affects dorsal/
ventral pathfinding of limb motor axons. Development 127, 3313–3324.
Hsieh, C.Y., Hong, C.T., and Cramer, K.S. (2007). Deletion of EphA4 enhances
deafferentation-induced ipsilateral sprouting in auditory brainstem projec-
tions. J. Comp. Neurol. 504, 508–518.
Huai, J., and Drescher, U. (2001). An ephrin-A-dependent signaling pathway
controls integrin function and is linked to the tyrosine phosphorylation of
a 120-kDa protein. J. Biol. Chem. 276, 6689–6694.
Huang, L.C., Thorne, P.R., Housley, G.D., and Montgomery, J.M. (2007).
Spatiotemporal definition of neurite outgrowth, refinement and retraction in
the developing mouse cochlea. Development 134, 2925–2933.
Huffman, K.J., and Cramer, K.S. (2007). EphA4misexpression alters tonotopic
projections in the auditory brainstem. Dev. Neurobiol. 67, 1655–1668.
Jhingory, S.,Wu, C.Y., and Taneyhill, L.A. (2010). Novel insight into the function
and regulation of alphaN-catenin by Snail2 during chick neural crest cell migra-
tion. Dev. Biol. 344, 896–910.
Kandpal, G., Jacob, A.N., and Kandpal, R.P. (1996). Transcribed sequences
encoded in the region involved in contiguous deletion syndrome that
comprises X-linked stapes fixation and deafness. Somat. Cell Mol. Genet.
22, 511–517.
Kelley, M.W. (2006). Regulation of cell fate in the sensory epithelia of the inner
ear. Nat. Rev. Neurosci. 7, 837–849.
Koundakjian, E.J., Appler, J.L., and Goodrich, L.V. (2007). Auditory neurons
make stereotyped wiring decisions before maturation of their targets.
J. Neurosci. 27, 14078–14088.
Kullander, K., and Klein, R. (2002). Mechanisms and functions of Eph and eph-
rin signalling. Nat. Rev. Mol. Cell Biol. 3, 475–486.
Lin, D.M., Fetter, R.D., Kopczynski, C., Grenningloh, G., and Goodman, C.S.
(1994). Genetic analysis of Fasciclin II in Drosophila: defasciculation, refasci-
culation, and altered fasciculation. Neuron 13, 1055–1069.
Meier, S., Sprecher, S.G., Reichert, H., and Hirth, F. (2006). Ventral veins
lacking is required for specification of the tritocerebrum in embryonic brain
development of Drosophila. Mech. Dev. 123, 76–83.
Mellitzer, G., Xu, Q., and Wilkinson, D.G. (1999). Eph receptors and ephrins
restrict cell intermingling and communication. Nature 400, 77–81.
Meyer, A.C., Frank, T., Khimich, D., Hoch, G., Riedel, D., Chapochnikov, N.M.,
Yarin, Y.M., Harke, B., Hell, S.W., Egner, A., and Moser, T. (2009). Tuning of
synapse number, structure and function in the cochlea. Nat. Neurosci. 12,
444–453.
Miko, I.J., Henkemeyer, M., and Cramer, K.S. (2008). Auditory brainstem
responses are impaired in EphA4 and ephrin-B2 deficient mice. Hear. Res.
235, 39–46.
Minowa, O., Ikeda, K., Sugitani, Y., Oshima, T., Nakai, S., Katori, Y., Suzuki, M.,
Furukawa, M., Kawase, T., Zheng, Y., et al. (1999). Altered cochlear fibrocytes
in a mouse model of DFN3 nonsyndromic deafness. Science 285, 1408–1411.
Montcouquiol, M., Rachel, R.A., Lanford, P.J., Copeland, N.G., Jenkins, N.A.,
and Kelley, M.W. (2003). Identification of Vangl2 and Scrb1 as planar polarity
genes in mammals. Nature 423, 173–177.
Mukai, S., Nakagawa, H., Ichikawa, H., Miyazaki, S., Nishimura, K., and
Matsuo, S. (2011). Effects of extracellular acidic-alkaline stresses on trigeminal
ganglion neurons in the mouse embryo in vivo. Arch. Toxicol. 85, 149–154.
Nemzou, N.R.M., Bulankina, A.V., Khimich, D., Giese, A., andMoser, T. (2006).
Synaptic organization in cochlear inner hair cells deficient for the CaV1.3
(alpha1D) subunit of L-type Ca2+ channels. Neuroscience 141, 1849–1860.
North, H.A., Zhao, X., Kolk, S.M., Clifford, M.A., Ziskind, D.M., and Donoghue,
M.J. (2009). Promotion of proliferation in the developing cerebral cortex by
EphA4 forward signaling. Development 136, 2467–2476.
Okazawa, H., Imafuku, I., Minowa, M.T., Kanazawa, I., Hamada, H., and
Mouradian, M.M. (1996). Regulation of striatal D1A dopamine receptor gene
transcription by Brn-4. Proc. Natl. Acad. Sci. USA 93, 11933–11938.
Neuron
Pou3f4/EphA4 in Spiral Ganglion Axon FasciculationOrioli, D., Henkemeyer, M., Lemke, G., Klein, R., and Pawson, T. (1996). Sek4
and Nuk receptors cooperate in guidance of commissural axons and in palate
formation. EMBO J. 15, 6035–6049.
Pan, L., Deng, M., Xie, X., and Gan, L. (2008). ISL1 and BRN3B co-regulate the
differentiation of murine retinal ganglion cells. Development 135, 1981–1990.
Pasquale, E.B. (2005). Eph receptor signalling casts a wide net on cell behav-
iour. Nat. Rev. Mol. Cell Biol. 6, 462–475.
Phillips, K., and Luisi, B. (2000). The virtuoso of versatility: POU proteins that
flex to fit. J. Mol. Biol. 302, 1023–1039.
Phippard, D., Heydemann, A., Lechner, M., Lu, L., Lee, D., Kyin, T., and
Crenshaw, E.B., 3rd. (1998). Changes in the subcellular localization of the
Brn4 gene product precede mesenchymal remodeling of the otic capsule.
Hear. Res. 120, 77–85.
Phippard, D., Lu, L., Lee, D., Saunders, J.C., and Crenshaw, E.B., 3rd. (1999).
Targetedmutagenesis of the POU-domain geneBrn4/Pou3f4 causes develop-
mental defects in the inner ear. J. Neurosci. 19, 5980–5989.
Pickles, J.O., Claxton, C., and Van Heumen, W.R. (2002). Complementary and
layered expression of Ephs and ephrins in developing mouse inner ear.
J. Comp. Neurol. 449, 207–216.
Puligilla, C., and Kelley, M.W. (2009). Building the world’s best hearing aid;
regulation of cell fate in the cochlea. Curr. Opin. Genet. Dev. 19, 368–373.
Puligilla, C., Dabdoub, A., Brenowitz, S.D., and Kelley, M.W. (2010). Sox2
induces neuronal formation in the developing mammalian cochlea.
J. Neurosci. 30, 714–722.
Raft, S., Koundakjian, E.J., Quinones, H., Jayasena, C.S., Goodrich, L.V.,
Johnson, J.E., Segil, N., and Groves, A.K. (2007). Cross-regulation of Ngn1
andMath1 coordinates the production of neurons and sensory hair cells during
inner ear development. Development 134, 4405–4415.Rubel, E.W., and Fritzsch, B. (2002). Auditory system development: primary
auditory neurons and their targets. Annu. Rev. Neurosci. 25, 51–101.
Ruben, R.J. (1967). Development of the inner ear of the mouse: a radioauto-
graphic study of terminal mitoses. Acta Otolaryngol. Suppl. 220, 221–244.
Ryan, A.K., and Rosenfeld, M.G. (1997). POU domain family values: flexibility,
partnerships, and developmental codes. Genes Dev. 11, 1207–1225.
Samadi, D.S., Saunders, J.C., and Crenshaw, E.B., 3rd. (2005). Mutation of the
POU-domain gene Brn4/Pou3f4 affects middle-ear sound conduction in the
mouse. Hear. Res. 199, 11–21.
Simmons, D., Duncan, J., Caprona, D.C., and Fritzsch, B. (2011). Development
of the inner ear efferent system. In Auditory and Vestibular Efferents, D.K.
Ryugo, R.R. Fay, and A.N. Popper, eds. (New York: Springer).
Smith, C.A. (1961). Innervation pattern of the cochlea. The internal hair cell.
Trans. Am. Otol. Soc. 49, 35–60.
Tessier-Lavigne, M., and Goodman, C.S. (1996). The molecular biology of
axon guidance. Science 274, 1123–1133.
van Heumen, W.R., Claxton, C., and Pickles, J.O. (2000). Expression of EphA4
in developing inner ears of the mouse and guinea pig. Hear. Res. 139, 42–50.
Wang, L., Klein, R., Zheng, B., and Marquardt, T. (2011). Anatomical coupling
of sensory and motor nerve trajectory via axon tracking. Neuron 71, 263–277.
Wilkinson, D.G. (2001). Multiple roles of EPH receptors and ephrins in neural
development. Nat. Rev. Neurosci. 2, 155–164.
Zhou, C.Q., Lee, J., Henkemeyer, M.J., and Lee, K.H. (2011). Disruption of
ephrin B/Eph B interaction results in abnormal cochlear innervation patterns.
Laryngoscope 121, 1541–1547.Neuron 73, 49–63, January 12, 2012 ª2012 Elsevier Inc. 63
